Oxford Biomedica and Santen sign ophthalmology R&D deal

UK biotech Oxford Biomedica and Japanese Santen have begun an option and licence agreement to research and develop gene therapy products for an inherited retinal disease. Inherited retinal diseases are a group of rare disorders caused by one of more than 260 different genes where mutation results in vision loss or blindness, often disproportionally affecting

Continue Reading

Novozymes sets up HelloScience, an online collaborative network for working on scientific solutions

Novozymes, a Danish biotech company, has set up an online network for individuals and companies to collaborate on solutions to major scientific problems called HelloScience. The network takes aim at five initial challenges, all based on a water theme, including developing an E. coli detection device. Approximately 18,000 children die each day from diarrhoea and

Continue Reading